1. Home
  2. STOK vs CBNK Comparison

STOK vs CBNK Comparison

Compare STOK & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • CBNK
  • Stock Information
  • Founded
  • STOK 2014
  • CBNK 1974
  • Country
  • STOK United States
  • CBNK United States
  • Employees
  • STOK N/A
  • CBNK N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • CBNK Major Banks
  • Sector
  • STOK Health Care
  • CBNK Finance
  • Exchange
  • STOK Nasdaq
  • CBNK Nasdaq
  • Market Cap
  • STOK 556.7M
  • CBNK 480.0M
  • IPO Year
  • STOK 2019
  • CBNK 2018
  • Fundamental
  • Price
  • STOK $7.21
  • CBNK $28.09
  • Analyst Decision
  • STOK Strong Buy
  • CBNK Hold
  • Analyst Count
  • STOK 8
  • CBNK 1
  • Target Price
  • STOK $23.83
  • CBNK $35.00
  • AVG Volume (30 Days)
  • STOK 868.5K
  • CBNK 47.5K
  • Earning Date
  • STOK 03-18-2025
  • CBNK 04-21-2025
  • Dividend Yield
  • STOK N/A
  • CBNK 1.42%
  • EPS Growth
  • STOK N/A
  • CBNK N/A
  • EPS
  • STOK N/A
  • CBNK 2.12
  • Revenue
  • STOK $36,555,000.00
  • CBNK $170,671,000.00
  • Revenue This Year
  • STOK N/A
  • CBNK $46.06
  • Revenue Next Year
  • STOK N/A
  • CBNK $8.25
  • P/E Ratio
  • STOK N/A
  • CBNK $13.25
  • Revenue Growth
  • STOK 316.34
  • CBNK 8.71
  • 52 Week Low
  • STOK $7.06
  • CBNK $19.02
  • 52 Week High
  • STOK $17.58
  • CBNK $32.88
  • Technical
  • Relative Strength Index (RSI)
  • STOK 34.49
  • CBNK 38.30
  • Support Level
  • STOK $7.18
  • CBNK $27.02
  • Resistance Level
  • STOK $8.45
  • CBNK $29.87
  • Average True Range (ATR)
  • STOK 0.60
  • CBNK 0.77
  • MACD
  • STOK -0.04
  • CBNK 0.06
  • Stochastic Oscillator
  • STOK 7.59
  • CBNK 37.54

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

Share on Social Networks: